Working toward a more serious clinical research path for BPC-157.
Better Peptide Company™ is focused on building the groundwork for regulated human research involving BPC-157 through structured study design, regulatory planning, and scientific oversight.
We are not selling peptide products or making treatment claims. Our focus is research planning and responsible clinical evaluation.
A company centered around controlled evaluation rather than online claims.
Public interest in BPC-157 has expanded quickly, while formal human clinical evidence remains limited. Better Peptide Company™ was created around the idea that compounds like BPC-157 should be evaluated through properly structured research rather than uncontrolled online use and anecdotal marketing.
Research focused
Our primary goal is evaluating whether BPC-157 can be studied through an appropriate clinical pathway.
No product sales
Better Peptide Company™ does not sell BPC-157, compounded peptides, or research chemicals.
No treatment claims
We do not claim that BPC-157 is safe, effective, approved, or appropriate for any medical condition.
An interdisciplinary founding team with business, engineering, and medical backgrounds.
Better Peptide Company™ is currently being developed by a small founding team with backgrounds spanning economics, business, biological engineering, and medical education.
Steele Yeargain
Steele earned his Bachelor of Science in Economics from Louisiana State University and is currently pursuing his MBA at Auburn University. His background is focused on business operations, fundraising strategy, and long-term company development within biotechnology.
Alex Goldberg
Alex earned his Bachelor of Science in Biological Engineering from Louisiana State University and will be pursuing his MD at LSU Health New Orleans. His background combines engineering and future clinical training with an interest in translational medicine.
Mikey Smith
Mikey earned his Bachelor of Science in Biological Engineering from Louisiana State University and is currently earning his master's degree in Exercise Physiology with a focus in Nutritional Science. His work is centered around hands-on research and performance physiology.
Building the foundation before increasing visibility.
The company is currently focused on the practical research and planning work that needs to exist before a serious clinical effort can move forward.
Scientific planning
Current work is focused on refining study direction, coordinating research efforts, and defining realistic next steps for formal evaluation.
Protocol refinement
An initial study protocol is being refined with attention to feasibility, oversight, safety monitoring, and long-term research practicality.
Appropriate pathway
The company is evaluating the appropriate sequence for research coordination, legal review, and future regulatory interaction.
Get in touch with Better Peptide Company™.
For research, regulatory, business, or general inquiries, use the contact form below. Please do not submit personal medical information or treatment requests.
contact@betterpeptidecompany.com